Skip to content

Effect of current stimulation on memory, attention in diabetes

Effect of transcranial direct current stimulation on cognitive impairment in type 2 Diabetes Mellitus :A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/03/024399
Enrollment
80
Registered
2020-03-31
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications

Interventions

Intervention1: Transcranial direct current stimulation: During Transcranial direct current stimulation, a constant direct current of low intensity current (generally 1–2 mA) will be passed across the

Sponsors

Abha Khisty
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Older adults diagnosed as type 2 Diabetes Mellitus more than 2 years and who are on oral antidiabetic medications. 2.Patients having HbA1c ranging from 6.0% to 8.5%, Recent reports of HbA1c i.e. within 1 month will be included. 3.Patients with score less than 24on Montreal cognitive assessment score 4 . Patients who have not undergone any supervised treatment protocol.

Exclusion criteria

Exclusion criteria: 1. Diagnosed cases of any neurodegenerative disorders including dementia or Alzheimer’s disease 2. Patients with recent myocardial infarction ,cardiac pacemakers 3. Older adults with history or presence of retinopathy, neuropathy. 4. Impaired skin over the placement of electrode which includes eczema, rashes, blisters, open wounds, burn, and cuts. 5. Patients operated with implanted metallic plates or stimulators in brain. 6. Patients with the history of previous neurosurgical procedures, neurologic malformations or brain neoplasia. 7. Patients with any epileptic disorders. 8. Patients with carotid shunts, tooth implants and dentures, implants anywhere in head neck face 9.Patients with uncontrolled Diabetes Mellitus. 10. Patients with hypertension and cardiac pacemakers.

Design outcomes

Primary

MeasureTime frame
Addenbrooke’s cognitive examination scoreTimepoint: Baseline at 0 Week and at 3 weeks

Secondary

MeasureTime frame
Montreal cognitive assessment scale 6 CIT scale Stroop test Timepoint: Baseline at 0 week and 3 weeks

Countries

India

Contacts

Public ContactDr Tushar J Palekar

Dr.D.Y.Patil College of physiotherapy

principal.physio@dpu.edu.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026